Vitamin D and the Indian Nutrimetabolic Phenotype: Insights from an Expert Panel Review
Vitamin D deficiency is highly prevalent in India despite abundant sunlight and may contribute to the broader Indian nutrimetabolic phenotype, characterized by central adiposity, insulin resistance, dyslipidemia, early β -cell dysfunction, and micronutrient insufficiencies. This expert review aimed to define the Indian nutrimetabolic phenotype, examine the contribution of vitamin D deficiency and related micronutrient factors, and provide practical guidance on screening, supplementation, and fortification strategies relevant to Indian clinical practice. A structured literature review was conducted using PubMed and Google Scholar, followed by a two-round Delphi process involving 14 endocrinologists. Evidence summaries and draft statements were rated anonymously, with consensus defined as ≥80% agreement; unresolved areas were refined during an in-person advisory board meeting. Consensus was reached on 22 expert insights organized under seven clinical questions and three thematic domains: phenotypic definition, prevention and risk management, and therapeutic supplementation principles. The panel concluded that the Indian nutrimetabolic phenotype is a modifiable construct shaped by diet, lifestyle, adiposity, metabolic risk, and micronutrient status and that vitamin D deficiency should be identified and corrected as part of comprehensive metabolic care, particularly in individuals with obesity, insulin resistance, type 2 diabetes mellitus/prediabetes, cardiovascular disease, and chronic kidney disease. Supplementation should be individualized according to baseline 25-hydroxyvitamin D levels, deficiency severity, body mass index, comorbidities, and safety considerations, with retesting after 8–12 weeks where appropriate. However, vitamin D should not be positioned as a standalone metabolic therapy or routine disease prevention strategy in vitamin D-sufficient individuals. Further studies in Indian populations are needed to validate population-specific thresholds, optimize dosing, and determine whether correction of deficiency improves clinically meaningful metabolic outcomes.
Authors
- Nitin Kapoor (ORCID: https://orcid.org/0000-0002-9520-2072)
- Nisha Bhavani (ORCID: https://orcid.org/0000-0002-7313-4275)
- Atul Dhingra (ORCID: https://orcid.org/0000-0003-3387-9157)
- Saptarshi Bhattacharya (ORCID: https://orcid.org/0000-0003-0053-1541)
- Himanshu Sharma (ORCID: https://orcid.org/0000-0001-7133-6327)
- Sambit Das (ORCID: https://orcid.org/0000-0001-5983-0453)
- Om Lakhani (ORCID: https://orcid.org/0000-0001-6954-3722)
- Lakshmi Nagendra (ORCID: https://orcid.org/0000-0001-6865-5554)
- Chitra Selvan
- Sanjay Kalra
- Sourabh Sharma
- K. V. S. Hari Kumar
- Ashok Kumar
Institutions
- JSS Academy of Higher Education and Research (IN)
- Amrita Institute of Medical Sciences and Research Centre (IN)
- Indraprastha Apollo Hospitals (IN)
- Safdarjang Hospital (IN)
- Christian Medical College, Vellore (IN)
- Vardhman Mahavir Medical College & Safdarjung Hospital (IN)
- Sarojini Naidu Medical College (IN)
- Ahmedabad Civil Hospital (IN)
- M.S. Ramaiah Medical College (IN)
- Bharti Hospital (IN)
- Tantia University (IN)
- Amrita Vishwa Vidyapeetham (IN)
- JSS Medical College and Hospital (IN)
Publication Details
- Journal
- Journal of Diabetology
- Published
- 2026-11-18
- DOI
- https://doi.org/10.4103/jod.jod_97_26
- Primary Topic
- Vitamin D Research Studies
- Type
- article
- Field-Weighted Citation Impact
- 0.00